Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea-Reference-Cited by-同舟云学术

Genomic characterization of patients with polycythemia vera developing resistance to hydroxyurea

Published:2020-05-05 Issue:2 Volume:35 Page:623-627
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Alvarez-Larrán Alberto, ,Díaz-González Alvaro,Such Esperanza,Mora Elvira,Andrade-Campos Marcio,García-Hernández Carmen,Gómez-Casares M. Teresa,García-Gutiérrez Valentín,Carreño-Tarragona Gonzalo,Garrote Marta,Fernández-Ibarrondo Lierni,Cervera José,Bellosillo Beatriz,Cervantes Francisco,Hernández-Boluda Juan Carlos^ORCID

Funder

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0849-2.pdf

Reference11 articles.

1. Alvarez-Larrán A, Pereira A, Cervantes F, Arellano-Rodrigo E, Hernández-Boluda JC, Ferrer-Marín F, et al. Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera. Blood. 2012;119:1363–9.

2. Alvarez-Larrán A, Kerguelen A, Hernández-Boluda JC, Pérez-Encinas M, Ferrer-Marín F, Bárez A, et al. Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera. Br J Haematol. 2016;172:786–93.

3. Demuynck T, Verhoef G, Delforge M, Vandenberghe P, Devos T. Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis. Ann Hematol. 2019;98:1421–6.